Pharsight

Ilumya patents expiration

List of large molecules

Patent Number Company Patent Title Patent Expiry Activity Alert
US8404813 NA Engineered anti-IL-23P19 antibodies
Feb, 2031

(6 years from now)

Ingredients: TILDRAKIZUMAB-ASMN